loadpatents
name:-0.56944513320923
name:-0.084749937057495
name:-0.02045202255249
STAFFLER; Guenther Patent Filings

STAFFLER; Guenther

Patent Applications and Registrations

Patent applications and USPTO patent grants for STAFFLER; Guenther.The latest application filed is for "peptide vaccines usable for hypercholesterolemia related diseases".

Company Profile
3.13.17
  • STAFFLER; Guenther - Vienna AU
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Peptide Vaccines Usable For Hypercholesterolemia Related Diseases
App 20210138048 - BRUNNER; Sylvia ;   et al.
2021-05-13
Peptide vaccines usable for hypercholesterolemia related diseases
Grant 10,933,123 - Brunner , et al. March 2, 2
2021-03-02
IL-23-p19 vaccines
Grant 10,576,131 - Staffler , et al.
2020-03-03
Il-23-p19 Vaccines
App 20200016249 - STAFFLER; Guenther ;   et al.
2020-01-16
Method of inhibiting C5a
Grant 10,344,062 - Staffler , et al. July 9, 2
2019-07-09
Treatment Using A Peptide And/or Vaccine
App 20180289781 - Brunner; Sylvia ;   et al.
2018-10-11
Peptide vaccines against PCSK9
Grant 10,004,791 - Galabova , et al. June 26, 2
2018-06-26
Treatments using a peptide and/or vaccine
Grant 9,999,659 - Brunner , et al. June 19, 2
2018-06-19
Method for detecting aSyn-specific antibodies in a biological sample
Grant 9,964,547 - Staffler , et al. May 8, 2
2018-05-08
Il-23-p19 Vaccines
App 20180110846 - STAFFLER; Guenther ;   et al.
2018-04-26
PCSK9 peptide combination vaccine and method of use
Grant 9,669,079 - Brunner , et al. June 6, 2
2017-06-06
Vaccines And Monoclonal Antibodies Targeting Truncated Variants Of Osteopontin And Uses Thereof
App 20170137509 - STAFFLER; Guenther ;   et al.
2017-05-18
Vaccine
App 20170112908 - BRUNNER; Sylvia ;   et al.
2017-04-27
Method for diagnosing alzheimer's disease (AD)
Grant 9,625,459 - Staffler , et al. April 18, 2
2017-04-18
Vaccines
App 20170065689 - GALABOVA; Gergana ;   et al.
2017-03-09
Vaccine capable of inducing formation of antibodies directed to proprotein convertase subtilisin/kexin type 9 (PCSK9) in vivo
Grant 9,533,030 - Brunner , et al. January 3, 2
2017-01-03
Methods for inhibiting C5a with C5a peptides coupled or fused to a carrier protein
Grant 9,457,078 - Staffler , et al. October 4, 2
2016-10-04
Pcsk9 Peptide Combination Vaccine And Method Of Use
App 20160106822 - BRUNNER; Sylvia ;   et al.
2016-04-21
Method For Detecting Asyn-specific Antibodies In A Biological Sample
App 20160054333 - STAFFLER; Guenther ;   et al.
2016-02-25
PCSK9 peptide combination vaccine and method of use
Grant 9,220,762 - Brunner , et al. December 29, 2
2015-12-29
Vaccine
App 20150306191 - BRUNNER; Sylvia ;   et al.
2015-10-29
Vaccine
App 20150166620 - Staffler; Guenther ;   et al.
2015-06-18
Vaccine
App 20150071951 - Brunner; Sylvia ;   et al.
2015-03-12
Method For Diagnosing Alzheimer's Disease (ad)
App 20140242727 - Staffler; Guenther ;   et al.
2014-08-28
Method For Detecting A Beta-specific Antibodies In A Biological Sample
App 20140234877 - Staffler; Guenther ;   et al.
2014-08-21
Vaccines Based On Peptides Of The Complement Protein C5a
App 20130216565 - Staffler; Guenther ;   et al.
2013-08-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed